These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 11560956)

  • 1. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes.
    Manjunath N; Shankar P; Wan J; Weninger W; Crowley MA; Hieshima K; Springer TA; Fan X; Shen H; Lieberman J; von Andrian UH
    J Clin Invest; 2001 Sep; 108(6):871-8. PubMed ID: 11560956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division.
    Oehen S; Brduscha-Riem K
    J Immunol; 1998 Nov; 161(10):5338-46. PubMed ID: 9820507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
    Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
    J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model.
    Ehl S; Hombach J; Aichele P; Hengartner H; Zinkernagel RM
    J Exp Med; 1997 Apr; 185(7):1241-51. PubMed ID: 9104811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences.
    Zimmermann C; Prévost-Blondel A; Blaser C; Pircher H
    Eur J Immunol; 1999 Jan; 29(1):284-90. PubMed ID: 9933110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo.
    Wiesel M; Crouse J; Bedenikovic G; Sutherland A; Joller N; Oxenius A
    Eur J Immunol; 2012 Feb; 42(2):320-9. PubMed ID: 22102057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
    Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
    Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear differentiation of cytotoxic effectors into memory T lymphocytes.
    Opferman JT; Ober BT; Ashton-Rickardt PG
    Science; 1999 Mar; 283(5408):1745-8. PubMed ID: 10073942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-15 induces unspecific effector functions in human peptide-specific CD8+ T-cell cultures.
    Lyngstrand ST; Würtzen PA; Ødum N; Nissen MH; Röpke C
    Scand J Immunol; 2002 Dec; 56(6):602-10. PubMed ID: 12472672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor cell persistence and activation-induced unresponsiveness of peripheral CD8+ T cells.
    Ehl S; Barchet W; Oehen S; Aichele P; Hombach J; Hengartner H; Zinkernagel RM
    Eur J Immunol; 2000 Mar; 30(3):883-91. PubMed ID: 10741405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential responsiveness to IL-2, IL-7, and IL-15 common receptor gamma chain cytokines by antigen-specific peripheral blood naive or memory cytotoxic CD8+ T cells from healthy donors and melanoma patients.
    Rosenthal R; Groeper C; Bracci L; Adamina M; Feder-Mengus C; Zajac P; Iezzi G; Bolli M; Weber WP; Frey DM; von Holzen U; Oertli D; Heberer M; Spagnoli GC
    J Immunother; 2009 Apr; 32(3):252-61. PubMed ID: 19242375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.
    Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A
    Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
    Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
    Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2-independent activity of IL-7 in the generation of secondary antigen-specific cytotoxic T cell responses in vitro.
    Kos FJ; Müllbacher A
    J Immunol; 1993 Jan; 150(2):387-93. PubMed ID: 8419472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The generation of memory antigen-specific cytotoxic T cell responses by CD28/CD80 interactions in the absence of antigen.
    Flynn K; Müllbacher A
    Eur J Immunol; 1997 Feb; 27(2):456-62. PubMed ID: 9045917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2/neu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. Divergent roles of IL-2 and IL-15.
    Efferson CL; Kawano K; Tsuda N; Palese P; García-Sastre A; Ioannides CG
    Anticancer Res; 2005; 25(2A):715-24. PubMed ID: 15868901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transgenic mouse model to analyze CD8(+) effector T cell differentiation in vivo.
    Manjunath N; Shankar P; Stockton B; Dubey PD; Lieberman J; von Andrian UH
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13932-7. PubMed ID: 10570176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2 and IL-15 regulate CD8+ memory T-cell differentiation but are dispensable for protective recall responses.
    Mathieu C; Beltra JC; Charpentier T; Bourbonnais S; Di Santo JP; Lamarre A; Decaluwe H
    Eur J Immunol; 2015 Dec; 45(12):3324-38. PubMed ID: 26426795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes.
    Love VA; Grabie N; Duramad P; Stavrakis G; Sharpe A; Lichtman A
    Circ Res; 2007 Aug; 101(3):248-57. PubMed ID: 17569889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.